Aaron Praiss

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician Satisfaction”.

Synoptic Reporting for Pretreatment CT Examination in Patients With Advanced Ovarian Cancer: Impact on Documentation of Disease Sites and Physician Satisfaction

American Journal of Roentgenology(2023)10.2214/ajr.23.29096

N/A

0.385DataRank · unranked

12 citations

Ines Nikolovski, Krishna Juluru, Elizabeth A. Sadowski, Natalie Gangai, Junting Zheng +10 more

Controversies in the Management of Mesonephric and Mesonephric-Like Adenocarcinomas of the Female Genital Tract

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101638

N/A

0.276DataRank · unranked

4 citations

Kay J. Park, Simran Makker, Jeffrey Girshman, Carol Aghajanian, Rachel N. Grisham +1 more

Is there a role for hyperthermic intraperitoneal chemotherapy in ovarian cancer?

Current Opinion in Obstetrics & Gynecology(2022)10.1097/gco.0000000000000837

N/A

0.241DataRank · unranked

4 citations

Lea A. Moukarzel, Oliver Zivanovic, Aaron Praiss

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.013

N/A

0.104DataRank · unranked

1 citations

Austin Miller, Judith A. Smith, Stuart M. Lichtman, Michael A. Bookman, Carol Aghajanian +17 more

Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.10.013

N/A

0DataRank · unranked

8 citations

Rahim Hirani, Qin Zhou, Alexia Iasonos, Yukio Sonoda, Nadeem R. Abu‐Rustum +7 more

Leave it in the past - primary treatment modality for high-grade epithelial ovarian cancer is not associated with secondary cytoreduction outcomes: A Memorial Sloan Kettering Cancer Center Team Ovary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.07.006

N/A

0DataRank · unranked

3 citations

Beryl Manning‐Geist, Sarah Ehmann, Jessica A. Lavery, Carrie Luardo, Aaron Praiss +10 more

Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets

Advances in Oncology(2023)10.1016/j.yao.2023.01.004

N/A

0DataRank · unranked

1 citations

Aaron Praiss, Chrisann Kyi, Kay J. Park, Rachel N. Grisham

Proposal of Novel Binary Grading Systems for Cervical Squamous Cell Carcinoma

International Journal of Gynecological Pathology(2023)10.1097/pgp.0000000000000979

N/A

0DataRank · unranked

1 citations

Aaron Praiss, Douglas Allison, Basile Tessier‐Cloutier, Jessica Flynn, Alexia Iasonos +13 more

Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.01.015

N/A

0DataRank · unranked

17 citations

Charlie White, Alexia Iasonos, Pier Selenica, Oliver Zivanovic, S. Dennis +7 more

Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtyping

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.09.012

N/A

0DataRank · unranked

11 citations

Christian Dagher, Qin Zhou, Alexia Iasonos, Eric Rios‐Doria, Nadeem R. Abu-Rustum +7 more

Gestational trophoblastic neoplasm: Patient outcomes and clinical pearls from a multidisciplinary referral center

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.12.009

N/A

0DataRank · unranked

2 citations

Aaron Praiss, Sarah Chiang, Kelly A. Devereaux, James Huang, Gabrielle Rizzuto +6 more

Evolution of tumor stress response during cytoreductive surgery for ovarian cancer

iScience(2025)10.1016/j.isci.2025.112317

N/A

0DataRank · unranked

1 citations

Lea A. Moukarzel, Yingjie Zhu, Ana Leda F. Longhini, Fatemeh Derakhshan, Timothy Hoang +18 more

Gastric-type adenocarcinoma of the cervix: Clinical outcomes and genomic drivers

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.003

N/A

0DataRank · unranked

48 citations

Dib Sassine, Alli Straubhar, Aaron Praiss, Carol Aghajanian, Kaled M. Alektiar +17 more

Mitogen-Activated Protein Kinase Driven Rare Gynecologic Cancers and Evolving Therapeutic Targets

Hematology/Oncology Clinics of North America(2025)10.1016/j.hoc.2025.04.015

N/A

0DataRank · unranked

0 citations

Aaron Praiss, Chrisann Kyi, Kay J. Park, Rachel N. Grisham

Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the cervix: A comprehensive international, multicenter, retrospective clinicopathologic study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.07.011

N/A

0DataRank · unranked

13 citations

Douglas Allison, Basile Tessier‐Cloutier, Jessica Flynn, Alexia Iasonos, Lien Hoang +15 more

TERT promoter mutations and gene amplification in endometrial cancer

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.10.007

N/A

0DataRank · unranked

12 citations

Antonio Marra, Qin Zhou, Eric Rios‐Doria, Amir Momeni Boroujeni, Alexia Iasonos +7 more

Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.02.003

N/A

0DataRank · unranked

10 citations

Qin Zhou, Alexia Iasonos, Lea A. Moukarzel, Kimberly Dessources, Krysten Soldan +11 more